Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Research Foundation Flanders | OTHER |
| Special Research Fund, Belgium | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to define preferential sites of tumour recurrence by observing tracer uptake in the tumour in sequential PET images with 18F-fluoromethylcholine (and perfusion MR, see also below). Changes in the intensity of the tracer uptake in the tumour during and after the course of radiotherapy will be correlated with the site of tumour recurrence as will be assessed by conventional MRI. In due time, these results must enable clinicians to change their therapeutic approach of high-grade glioma.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | 18F-fluoromethylcholine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PET images with 18F-fluoromethylcholine | Radiation | sequential PET images with 18F-fluoromethylcholine |
|
| Measure | Description | Time Frame |
|---|---|---|
| time to local recurrence after neurosurgery and adjuvant radiochemotherapy | 18 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ingeborg Goethals, MD, PhD | University Hospital, Ghent | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Ghent | Ghent | 9000 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C516370 | fluoromethylcholine |
Not provided
Not provided
Not provided